{"id":"https://openalex.org/A5119986946","orcid":"https://orcid.org/0009-0009-0604-9079","observed_orcids":["https://orcid.org/0009-0009-0604-9079"],"display_name":"Mohammad A. Farhoud","raw_author_names":["Mohammad A Farhoud","Mohammad A. Farhoud"],"full_name":"Mohammad A. Farhoud","works_count":3,"cited_by_count":3,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5119986946","orcid":"https://orcid.org/0009-0009-0604-9079","observed_orcids":["https://orcid.org/0009-0009-0604-9079"]},"affiliations":[{"institution":{"id":"https://openalex.org/I103320735","ror":"https://ror.org/03h7r5v07","display_name":"Universit\u00e0 Cattolica del Sacro Cuore","country_code":"IT","type":"education","lineage":["https://openalex.org/I103320735"]},"years":[2026,2025]},{"institution":{"id":"https://openalex.org/I98635879","ror":"https://ror.org/04pznsd21","display_name":"American University of Beirut","country_code":"LB","type":"education","lineage":["https://openalex.org/I98635879"]},"years":[2025]}],"last_known_institutions":[{"id":"https://openalex.org/I103320735","ror":"https://ror.org/03h7r5v07","display_name":"Universit\u00e0 Cattolica del Sacro Cuore","country_code":"IT","type":"education","lineage":["https://openalex.org/I103320735"]}],"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","count":3,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","count":2,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","count":2,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","count":1,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","count":1,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","value":1.4e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","value":1.32e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","value":6.9e-06,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","value":6.9e-06,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","value":4.9e-06,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","score":0.8535000085830688},{"id":"2781024287","wikidata":"https://www.wikidata.org/wiki/Q774909","display_name":"Thromboxane A2","score":0.7953000068664551},{"id":"89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","score":0.6462000012397766},{"id":"2776785769","wikidata":"https://www.wikidata.org/wiki/Q412212","display_name":"Thromboxane","score":0.4715000092983246},{"id":"3018697912","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Platelet activation","score":0.4715000092983246}],"counts_by_year":[{"year":2025,"works_count":2,"oa_works_count":1,"cited_by_count":0},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":3}],"display_name_alternatives":["Mohammad A Farhoud","Mohammad A. Farhoud"],"block_key":"m farhoud","works_api_url":"https://api.openalex.org/works?filter=author.id:A5119986946","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5119986946","updated_date":"2026-11-16T12:53:42","created_date":"2025-10-14T00:00:00"}
